Medical

OspA vaccine

OspA vaccine

Infectious disease A vaccine containing recombinant outer-surface protein A of B burgdorferi, the Lyme disease agent. See Borrelia burgdorferi, Lyme disease.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in
References in periodicals archive
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: A double-blind, randomised, dose-escalation phase 1/2 trial.
A novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi Sensu Lato.
Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State.
A systematic review and meta-analysis for the adverse effects, immunogenicity and efficacy of Lyme disease vaccines: guiding novel vaccine development
Evaluation of the C6 peptide enzyme-linked immunosorbent assay www.mlo-online.com for individuals vaccinated with the recombinant OspA vaccine. J.
The evolution of Borrelia serology tests
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.